Peritoneal immune cells reside unanchored within the peritoneal fluid in homeostasis. Here, we examined the mechanisms that control bacterial infection in the peritoneum using a mouse model of abdominal sepsis following intraperitoneal Escherichia coli infection. Whole-mount immunofluorescence and confocal microscopy of the peritoneal wall and omentum revealed that large peritoneal macrophages (LPMs) rapidly cleared bacteria and adhered to the mesothelium, forming multilayered cellular aggregates composed by sequentially recruited LPMs, B1 cells, neutrophils, and monocyte-derived cells (moCs). The formation of resident macrophage aggregates (resMφ-aggregates) required LPMs and thrombin-dependent fibrin polymerization. E. coli infection triggered LPM pyroptosis and release of inflammatory mediators. Resolution of these potentially inflammatory aggregates required LPM-mediated recruitment of moCs, which were essential for fibrinolysis-mediated resMφ-aggregate disaggregation and the prevention of peritoneal overt inflammation. Thus, resMφ-aggregates provide a physical scaffold that enables the efficient control of peritoneal infection, with implications for antimicrobial immunity in other body cavities, such as the pleural cavity or brain ventricles.
Pubmed ID: 34717795 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Commercial supplier and developer of in vivo antibodies. Provides antibodies and antibody production services.
View all literature mentionsSoftware for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsThis monoclonal targets Ly6G
View all literature mentionsThis monoclonal targets Ly6G/Ly6C (Gr-1)
View all literature mentionsThis monoclonal targets ZO-1
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis unknown targets SOWAHA
View all literature mentionsThis monoclonal targets Podoplanin
View all literature mentionsThis monoclonal targets Phospho-MLKL (Ser358)
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis recombinant monoclonal targets GSDMD
View all literature mentionsThis polyclonal targets Human Fibrinogen
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets Tim-4
View all literature mentionsThis polyclonal targets Mouse Coagulation Factor III / Tissue Factor
View all literature mentionsThis unknown targets Biotin
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis unknown targets Ki-67
View all literature mentionsThis monoclonal targets CD54 (ICAM-1)
View all literature mentionsThis monoclonal targets MHC Class II (I-A/I-E)
View all literature mentionsThis monoclonal targets GATA6
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD90.2
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentions